Karl U. Ulrich Bartz-Schmidt

Prevalence of Age-Related Macular Degeneration in Europe

Yara T. E. Lechanteur, Christine Binquet, Elena Prokofyeva, 2017, Ophthalmology.

Predicting progression to advanced age-related macular degeneration from clinical, genetic and lifestyle factors using machine learning.

A. Hofman, H. Jacqmin-Gadda, A. D. den Hollander, 2020, Ophthalmology.

Increased High-Density Lipoprotein Levels Associated with Age-Related Macular Degeneration: Evidence from the EYE-RISK and European Eye Epidemiology Consortia.

Christine Binquet, Elena Prokofyeva, Usha Chakravarthy, 2018, Ophthalmology.

Bevacizumab for choroidal neovascularization secondary to pathologic myopia: Is there a decline of the treatment efficacy after 2 years?

W. Inhoffen, F. Ziemssen, F. Gelisken, 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.

Is intravitreal bevacizumab treatment effective in diffuse diabetic macular edema?

F. Ziemssen, F. Gelisken, Karl U. Ulrich Bartz-Schmidt, 2009, Graefe's Archive for Clinical and Experimental Ophthalmology.

Integrating metabolomics, genomics and disease pathways in age-related macular degeneration: The EYE-RISK Consortium.

H. Hense, C. Klaver, A. D. den Hollander, 2020, Ophthalmology.

Mediterranean Diet and Incidence of Advanced Age-Related Macular Degeneration: The EYE-RISK Consortium.

O. Franco, A. D. den Hollander, E. V. van Leeuwen, 2019, Ophthalmology.